These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 14508092)

  • 1. Chemoprevention strategies using NSAIDs and COX-2 inhibitors.
    Keller JJ; Giardiello FM
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S140-9. PubMed ID: 14508092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
    Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K; Akay MT; Abbasoglu O; Ercan A
    Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 inhibitors: cancer trials test new uses for pain drug.
    Michalowski J
    J Natl Cancer Inst; 2002 Feb; 94(4):248-9. PubMed ID: 11854385
    [No Abstract]   [Full Text] [Related]  

  • 7. COX-2-Selective NSAIDs: new and improved?
    Lichtenstein DR; Wolfe MM
    JAMA; 2000 Sep; 284(10):1297-9. PubMed ID: 10980759
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of cyclooxygenase-2-specific inhibitors.
    Cannon GW; Breedveld FC
    Am J Med; 2001 Feb; 110 Suppl 3A():6S-12S. PubMed ID: 11173044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2-specific inhibition: implications for clinical practice.
    Pascucci RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S18-22. PubMed ID: 10643177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
    Steinbach G; Lynch PM; Phillips RK; Wallace MH; Hawk E; Gordon GB; Wakabayashi N; Saunders B; Shen Y; Fujimura T; Su LK; Levin B; Godio L; Patterson S; Rodriguez-Bigas MA; Jester SL; King KL; Schumacher M; Abbruzzese J; DuBois RN; Hittelman WN; Zimmerman S; Sherman JW; Kelloff G
    N Engl J Med; 2000 Jun; 342(26):1946-52. PubMed ID: 10874062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives].
    Rioda WT; Nervetti A
    Acta Biomed Ateneo Parmense; 2001; 72(3-4):55-64. PubMed ID: 11889908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arthritis drug approved for polyp prevention blazes trail for other prevention trials.
    Smigel K
    J Natl Cancer Inst; 2000 Feb; 92(4):297-9. PubMed ID: 10675374
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoprevention comes to clinical practice: COX-2 inhibition in familial adenomatous polyposis.
    Bresalier RS
    Gastroenterology; 2000 Dec; 119(6):1797-8. PubMed ID: 11113106
    [No Abstract]   [Full Text] [Related]  

  • 14. COX-2 inhibitors for colorectal cancer.
    Elder DJ; Paraskeva C
    Nat Med; 1998 Apr; 4(4):392-3. PubMed ID: 9546780
    [No Abstract]   [Full Text] [Related]  

  • 15. NSAIDs and chemoprevention.
    Rao CV; Reddy BS
    Curr Cancer Drug Targets; 2004 Feb; 4(1):29-42. PubMed ID: 14965265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of colorectal cancer: tumor progression, chemoprevention, and COX-2 inhibition.
    Bresalier RS
    Gastroenterology; 2000 Jul; 119(1):267-8. PubMed ID: 10889181
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile?
    Simon LS
    Gastroenterol Clin North Am; 2001 Dec; 30(4):1011-25, viii. PubMed ID: 11764530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new NSAIDs: cox-2 inhibitors.
    Capriotti T
    Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.